Friday, April 3, 2026

Latest
S&P Slashes British Columbia Rating Again, Citing Fiscal Imbalances
Defense Secretary Hegseth Fires Army Chief Randy George in Leadership Shake-Up
Security Threats Force Shen Yun to Cancel Remaining Toronto Shows, Raising Venue Safety Questions
Kash Patel Faces Trump’s Axe Following Pam Bondi’s Exit as Attorney General
SpaceX Boosts IPO Target to Over $2 Trillion, Setting Stage for Historic Listing
A New Loan Collateral: Tariff Refunds
BC NDP Mounts Secret Campaign to Derail Alberta’s Northern Oil Pipeline
La Presse Suspends The Food Professor Column After Media Critique
Trump Axes AG Bondi, Taps Todd Blanche as Acting Replacement
Foreign Ownership of US Treasuries Falls to Lowest Share Since 1997, With No Floor in Sight
Search

Revive Therapeutics

Revive Therapeutics Considers Exploring Bucillamine For Treatment Of Monkeypox
August 29, 2024, 10:31:20 AM
Read More

Revive Therapeutics Announces Final Stages In Bucillamine Phase 3 Clinical Trial For COVID-19
January 19, 2022, 09:28:00 AM
Read More

Revive Therapeutics Adds Turkish Subjects To Bucillamine Phase 3 Clinical Trial For COVID-19
December 30, 2021, 12:49:00 PM
Read More

Revive Therapeutics Includes Treating Omicron Variant In Bucillamine Research
December 3, 2021, 02:56:00 PM
Read More

Revive Therapeutics Announces Research Collaboration Agreement For Psilocybin Microneedle Patch
November 3, 2021, 09:29:00 AM
Read More

Revive Therapeutics Enters Exclusive License For Ganoderma Lucidum Intellectual Property
August 18, 2021, 09:23:10 AM
Read More

Revive Therapeutics Provides Update On Current Psilocybin Programs
August 10, 2021, 08:36:06 AM
Read More

Revive Therapeutics Begins Laying Groundwork For Commercialization Of Bucillamine
July 15, 2021, 02:27:50 PM
Read More

Revive Therapeutics Partners With University of Health Sciences Antigua To Further Psychedelics Research
June 17, 2021, 08:45:27 AM
Read More

Revive Therapeutics Looks To Bring Bucillamine To India
June 8, 2021, 09:15:00 AM
Read More
Latest News
S&P Slashes British Columbia Rating Again, Citing Fiscal Imbalances
Defense Secretary Hegseth Fires Army Chief Randy George in Leadership Shake-Up
Security Threats Force Shen Yun to Cancel Remaining Toronto Shows, Raising Venue Safety Questions
Kash Patel Faces Trump’s Axe Following Pam Bondi’s Exit as Attorney General
SpaceX Boosts IPO Target to Over $2 Trillion, Setting Stage for Historic Listing
A New Loan Collateral: Tariff Refunds
BC NDP Mounts Secret Campaign to Derail Alberta’s Northern Oil Pipeline
La Presse Suspends The Food Professor Column After Media Critique
Trump Axes AG Bondi, Taps Todd Blanche as Acting Replacement
Foreign Ownership of US Treasuries Falls to Lowest Share Since 1997, With No Floor in Sight
Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA
Recommended

First Majestic Aims To Restart Production At Jerritt Canyon In H2 2027

Mercado Minerals Identifies A Series Of New Targets Following LiDAR Survey At Copalito
Trending
© 2026
the deep dive
Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.